Hubei Jumpcan Pharmaceutical Co., Ltd.

Shanghai Stock Exchange:600566.SS

Sector

🏥 Health Care

Industries

💊 Pharmaceuticals

🧬 Biotechnology

🔬 Clinical Trials

🏥 Hospitals & Clinics

💻 Telehealth

Location

China

Market Cap

USD 3.62 B

Share Price

USD 3.93

Avg Daily Volume

6,023,021

Change (1 day)

1.22%

Change (1 year)

-13.49%

Change (YTD)

-1.36%

Hubei Jumpcan Pharmaceutical Co., Ltd. Operating Income Margin for the year ending December 31, 2024: 35.71%

Hubei Jumpcan Pharmaceutical Co., Ltd. Operating Income Margin is 35.71% for the year ending December 31, 2024, a 5.82% change year over year. Operating Income Ratio is the proportion of a company's operating income to its net sales, measuring the efficiency of its core business operations in generating profits.

Hubei Jumpcan Pharmaceutical Co., Ltd. Operating Income Margin for the year ending December 31, 2023 was 33.75%, a 25.27% change year over year.
Hubei Jumpcan Pharmaceutical Co., Ltd. Operating Income Margin for the year ending December 31, 2022 was 26.94%, a 6.35% change year over year.
Hubei Jumpcan Pharmaceutical Co., Ltd. Operating Income Margin for the year ending December 31, 2021 was 25.33%, a 6.31% change year over year.
Hubei Jumpcan Pharmaceutical Co., Ltd. Operating Income Margin for the year ending December 31, 2020 was 23.83%, a -10.98% change year over year.

Quarterly
Annual
TTM

From:

To:

Zoom:

Key data

Date	Operating Income Margin	Gross Profit Margin	EBIT Margin	EBITDA Margin

Shanghai Stock Exchange: 600566.SS

Hubei Jumpcan Pharmaceutical Co., Ltd.

CEO	Mr. Fei Cao
IPO Date	Aug. 22, 2001
Location	China
Headquarters	Baota Bay
Employees	5,230
Sector	🏥 Health Care
Industries Pharmaceuticals 🧬 Biotechnology 🔬 Clinical Trials 🏥 Hospitals & Clinics 💻 Telehealth

Description

Hubei Jumpcan Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, and trading of Chinese traditional medicines, western medicines, daily use chemical based Chinese traditional medicines, and Chinese medicine health products in China. The company offers Chinese and western medicines in the areas of pediatrics, gynecology, pneumology, gastroenterology, and geriatrics; oral and skin care products; and anti-fatigue, anti-aging, antioxidant, and immunity-enhancing Chinese medicine health products. It also develops Chinese and western medicines in the areas of detoxification, digestive system, respiratory system, nervous system, anti-infection, cardiovascular, narcotic analgesic, nutrition, musculoskeletal, and hemostasis. The company was formerly known as Hubei Hongcheng General Machinery Co., Ltd and changed its name to Hubei Jumpcan Pharmaceutical Co., Ltd. in March 2015. Hubei Jumpcan Pharmaceutical Co., Ltd. is based in Taixing, China.